Home
Online Journal
Media Info
Event list
Partners
Advisory board
About us
Contact
Jobs
Web Advertisement
Biotech
Clinical Research
Clusters
Food & Health
Law & Insurance
Medtech
Nano & Biomaterials
Pharma
Science Parks/org
Webcast
Press Releases
Markets & Trends
Welcome to the
European Life Science Journal for international business
Get inspired by the entrepreneurs leading the way of tomorrow´s life science businesses !
Press Releases
2012-02-21
(0 kommentarer)
International Oncology Conference
Oncology is one of the fast progressing fields in medicine. Oncologists world over are finding cure for cancer. Fleming Gulf Conferences has taken an initiative to bring all the oncologists together through The international Oncology Conference 2012. The conference will be held in Dubai from 17 - 18 May. From world over doctors, researchers and other medical experts twill come...
2012-02-20
(0 kommentarer)
An ocean of fuels
Copenhagen/Bangalore – Biofuels need reliable sources of biomass. Novozymes now looks to the ocean to secure biomass. The Danish enzyme specialist announced an exploratory research agree...
2012-02-17
(0 kommentarer)
Clavis Pharma gets €21m for anti-cancer pipeline
Oslo – The north lights up with financial flares. Norwegian cancer specialist Clavis Pharma ASA has raised €21m through a placement of new shares. The 2.8 million shares represent approximate...
2011-09-14
(0 kommentarer)
Uppsala BIO signs first European open innovation agreement with Roche for its program BIO-X
Swedish life science initiative Uppsala BIO has formed a strategic partnering agreement with Roche, the world leading pharmaceuticals and diagnostics company, for Uppsala BIO’s open inn...
2011-08-25
(0 kommentarer)
Global proteomics researchers gather to advance the Human Proteome Project at HUPO 2011
Leading proteomics researchers are gathering at the HUPO 2011 meeting in Geneva, Switzerland, to define new short-term milestones for the Human Proteome Project (HPP). This global collaborati...
2011-08-19
(0 kommentarer)
MipTec 2011: Newest discoveries and innovations to be presented at the international life sciences meeting point in Basel
From 20 – 22 September 2011, Basel will turn again into the international meeting point in the field of Life Sciences. The MipTec Drug Discovery Conference will take place for the first time ...
2011-08-15
(0 kommentarer)
Stanford researchers separate tumor-causing stem cells from therapeutic one
A major obstacle to widespread therapeutic use of human embryonic stem cells in therapy is this nasty tendency for a few of them to turn "Frankenstein" on us. Out of the tens of millions of p...
2011-06-15
(0 kommentarer)
Mendor collaboration with Novartis Finland
Finnish growth company Mendor starts collaboration with a global pharma corporation to develop diabetes treatmentMedical device growth company Mendor has started a local collaboration in Finl...
2011-06-14
(0 kommentarer)
Swedish technology producing major efficiencies, cost savings for Canadian hospitals, states Swedens ambassador to Canada
TORONTO, June 14, 2011 /CNW/ - Swedish technology is playing a major role in helping Canadian hospitals operate more efficiently and realize significant cost savings, said Teppo Tauriainen, S...
2011-06-01
(0 kommentarer)
Stem cell technology used in unique surgery in Gothenburg
Prof. Michael Olausson, responsible for the unique surgery at Sahlgrenska University Hospital.Photo: Björn Larsson RosvallFor the first time ever in the world, researchers at the Sahlgrenska ...
2011-06-01
(0 kommentarer)
Washington DC breakfast offers insights on designing your regulatory strategy
These days, getting a dialogue started with regulators at a very early stage of development is one of the most important tasks for any biotech company. Their feedback on trial design, special...
2011-05-31
(0 kommentarer)
Clavis Pharma receives government grant to develop hENT1 biomarker assay for targeted therapy of AML patients
Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, is pleased to announce that it has been awarded a grant from The Research Council of Norway of up to NOK 14 mil...
2011-05-31
(0 kommentarer)
Separating ELA from the Crowd
Inaugural Advances in Separation Technology Conference to Join Streams at ELASelect Biosciences, organisers of European Lab Automation (ELA) 2011, today announced that the inaugural Advances ...
2011-05-31
(0 kommentarer)
How can genetic research help beat stomach cancer?
STOMACH cancer affects about 530 Victorians each year, more commonly people aged over 50. Now a team of Monash Institute of Medical Research scientists has zeroed in on a gene that may contri...
2011-04-06
(0 kommentarer)
Bibby Scientific looks to the East with sales office in Singapore
Bibby Scientific’s newest sales office is located in Singapore, opening up opportunities to build closer relationships with customers and dealers in the whole Asian region, including China, S...
2011-03-31
(0 kommentarer)
New Osteoporosis Assay From Astra Biotech Gmbh
Osteoporosis affects over 75 million people worldwide and in a single year there are more than 9 million instances of osteoporotic fractures making it the fourth most significant non-infectio...
2011-03-09
(0 kommentarer)
Navigators Expands Swedish Underwriting Agency, NUAL AB
NEW YORK, March 1, 2011—The Navigators Group, Inc. (NASDAQ:NAVG) today announced that its Swedish underwriting agency, NUAL AB, will now be offering Life Sciences insurance solutions. Magnus ...
2011-02-02
(0 kommentarer)
Fast Eight-Channel Nucleic Acid Analysis
The world`s first true eight-channel, micro-volume spectrophotometer for measuring DNA,RNA and Proteins will be launched at the Pittcon exhibition in March.AstraNet Systems Ltd...
2010-10-28
(0 kommentarer)
A change of culture for healthcare
A new committee of healthcare specialists believes that culture change within the industry must be targeted in one of two ways: either their first objective is to ‘do what you do better’ or l...
2010-10-13
(0 kommentarer)
Vitrolife expands its IVF product portfolio through acquisition in the USA.
Vitrolife is acquiring the business in Conception Technologies, USA. This means that Vitrolife will broaden their IVF product portfolio, increase cost-efficient production capacity and increase its...
2010-10-08
(0 kommentarer)
Genzyme Board Unanimously Rejects Sanofi-Aventis Tender Offer
Genzyme announced today that its board of directors has voted unanimously to reject the unsolicited $69.00 per share tender offer from Sanofi-Aventis, and the board recommends that Genzyme sh...
2010-10-07
(0 kommentarer)
Fisher Scientific launches new e-catalogue for all Swedish laboratories.
LABORATORY EQUIPMENT: The new e-catalogue is readily accessible on the Internet in a user-friendly format. It is easy to turn pages using the mouse and the catalogue offers a product overview...
2010-10-05
(0 kommentarer)
Major investment in women’s health UP TO $330M CAD INTERNATIONAL PARTNERSHIP BETWEEN BAYER HEALTHCARE PHARMACEUTICALS AND ENDOCEUTICS INC.
Bayer HealthCare Pharmaceuticals (Bayer) and EndoCeutics Inc., Québec, are proud to announce the signing of an exclusive international collaborative agreement for Phase III development ...
2010-10-05
(0 kommentarer)
Biospain 2010: Spanish biotech industry looks for a global path
Biotechnology has emerged in Spain as a key force driving economic change, estimated to contribute as much as 1.6 percent to the total GDP; with a total workforce of 100,000 highly qualified ...
2010-10-04
(0 kommentarer)
Pharmatest signes a master service agreement with bayer Schering Pharma AG
Pharmatest Services Ltd, a Finnish CRO specializing in non-clinical pharmalogical research services has signed a Master Service Agreement with bayer Schering Pharma AG, Germany.Pharmatest provides ...
2010-10-01
(0 kommentarer)
New outcomes study for ticagrelor (BRILINTA) to examine longer-term treatment for post- ACS patients
AstraZeneca today announced the initiation of a large, international, clinical outcomes study for the investigational oral antiplatelet, ticagrelor (BRILINTATM/BRILIQUETM) in collaboration wi...
2010-09-30
(0 kommentarer)
AstraZeneca pays Riegel 25 million USD for arthritis drug`s milestones
Rigel Pharmaceuticals earned $25 million from British drugmaker AstraZeneca after reaching two development milestones for a rheumatoid arthritis treatment.Rigel said Wednesday it reached one ...
2010-09-29
(0 kommentarer)
Early prostate test study gives hope for accuracy
British scientists say they have developed a lab test that can accurately distinguish prostate cancer from healthy tissue and other prostate conditions -- a finding that may in future help me...
2010-09-29
(0 kommentarer)
Novo leads $31M round for Tobiras game-changing HIV program
Novo A/S has stepped up to lead a $31 million Series B for Tobira Therapeutics, a New Jersey-based biotech that is pushing a next-gen HIV antiviral compound into a Phase IIb trial.Tobiras lea...
2010-09-28
(0 kommentarer)
Biotechnology poised to be Taiwan´s next high-tech success story
Taiwan has achieved remarkable economic success, having transformed itself in a few short decades to the technology-driven economic powerhouse that it is today.Over the past 20 years Taiwan h...
2010-09-15
(0 kommentarer)
EFIB 2010 turns Edinburgh into the city of industrial biotechnology for a week
EFIB 2010 turns Edinburgh into the city of industrial biotechnology for a weekThis years EFIB conference offers unrivalled networking opportunities with the exhibition being almost sold out, ...
2010-09-14
(0 kommentarer)
The Aminoff Prize 2011: Biological minerals inspires for the future
The Royal Swedish Academy of Sciences has awarded The Gregori Aminoff Prize in crystallography 2011 to Professor Lia Addadi and Professor Stephen Weiner, both at the Weizmann Institute of Sci...
2010-09-08
(0 kommentarer)
ECCP 2010 - The Oncology Partnering Event in Europe for Biotechs, Pharma, Investors, and Academia
The Oslo Cancer Cluster (Oslo, Norway) and the Cancer - Bio - Santé Cluster (Toulouse, France) welcome key players from the international oncology community to Oslo, Norway.ECCP2010 is a meet...
2010-09-07
(0 kommentarer)
Roche and reMYND enter into a strategic alliance to develop first-in-class disease-modifying treatments for Parkinson’s and Alzheimer’s disease
Roche and reMYND today announced that they have entered into an agreement to develop novel therapeutics that could slow down neurodegeneration in Parkinson’s and Alzheimer’s patients by...
2010-09-03
(0 kommentarer)
Scientists discover protein that fuels Alzheimers disease
Researchers at Fisher Center for Alzheimers Disease Research Laboratory, US, have published "Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimers Disease" in Nature onlin...
2010-09-03
(0 kommentarer)
Meda will acquire Alaven Pharmaceutical
Meda has signed an agreement to acquire the US specialty pharmaceutical company Alaven that develop and market prescription and non-prescription products that treat women`s health, gastroente...
2010-09-03
(0 kommentarer)
Nexus Becomes Pioneering International Member of Prestigious Scandinavian Cancer Organisation
Nexus Oncology has announced it has joined the Oslo Cancer Cluster (OCC). Nexus becomes the first non-Scandinavian company to join the OCC, a non-profit member organisation that seeks to acce...
2010-09-02
(0 kommentarer)
Sigma Life Science launches range of engineered cell lines exploiting CompoZr® zinc finger nuclease technology
SigmaLife Science, the innovative biological products and research services business of Sigma-Aldrich® Corporation (Nasdaq:SIAL), today announced the global release of a pioneering range of enginee...
2010-08-24
(0 kommentarer)
Gyros AB launches new corporate website
24 August 2010, Uppsala, Sweden: Gyros AB has launched a new website to support its position as the leader in utilization of microfluidic technologies to miniaturize and automate immunoassays. The...
2010-08-20
(0 kommentarer)
Dr. Reddys chooses to implement Werums MES
Lueneburg, Germany, August 20, 2010 – Indian pharmaceutical major Dr. Reddys Laboratories Ltd. has decided to introduce PAS-X, the Manufacturing Execution System (MES) by Werum Software & Syste...
2010-08-19
(0 kommentarer)
Clinical benefits of radioactive microspheres
Multi-centre Phase II Trial reports safety and clinical benefits of radioactive microspheres in patients with colorectal cancer liver metastases who have failed chemotherapy. Rome – 19 August 2010...
1900-01-01
(0 kommentarer)
Oncology is one of the fast progressing fields in medicine. Oncologists world over are finding cure for cancer. Fleming Gulf Conferences has taken an initiative to bring all the oncolog...
Banners
Bio IT
Bio material
Bio Suppliers / Distributors
Bio Suppliers / Manufacturers
Consulting
CRO
Diagnostics
Drug Design
Events
Food Health
Genomics
Health care
Hospitals
Intellectual
Investors
Laboratories
Nanotech
Organisations
Pharma
Science Parks
Services
Technology centres
Universities
Contract Manufacturing